Search

everythinglearnresearchcommunity

for

Search:↓

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Hirsutism is when women have too much hair growth, often due to a bit more androgen hormones and sensitive skin.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

New treatments for PCOS focus on managing symptoms and improving fertility.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Spironolactone can reduce hair growth in women with hirsutism.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.